Home »
Rulemaking » Start-Up Option Exclusive License: Development of Liposomal Therapeutic Agents for Treatment of Human Epithelial Cancers and Liposarcomas
Start-Up Option Exclusive License: Development of Liposomal Therapeutic Agents for Treatment of Human Epithelial Cancers and Liposarcomas
Start-Up Option Exclusive License: Development of Liposomal Therapeutic Agents for Treatment of Human Epithelial Cancers and Liposarcomas
Details Information
Comments
Related Documents